Press release
Active Pharmaceutical Ingredients CDMO Market to Reach USD 193.8 Billion by 2030 with Strong Growth in Oncology, Asia-Pacific Expansion
Active Pharmaceutical Ingredients CDMO Market Size & Trends | Mordor Intelligence
The Active Pharmaceutical Ingredients CDMO Market Size is anticipated to grow from USD 128.26 billion in 2025 to USD 193.83 billion by 2030, registering a CAGR of 8.61% over this period. This expansion reflects growing demand across the drug development spectrum-for process development, near-term supply, and commercial manufacturing of high-value APIs. As pharmaceutical firms, especially in oncology and biologics, continue to outsource API production, CDMOs are stepping up with integrated service models that can handle complex molecules and large-scale supply.
Report Overview: https://www.mordorintelligence.com/industry-reports/active-pharmaceutical-ingredients-cdmo-market?utm_source=openpr
Key Trends in the Active Pharmaceutical Ingredients CDMO Market
Key Active Pharmaceutical Ingredients CDMO Market Trends shaping the market include:
Oncology remains the top application area
CDMOs are seeing the greatest demand in oncology-related API manufacturing. This reflects growing R&D pipelines targeting cancer therapies and the complexity of molecules being developed.
Synthetic and innovative drugs lead demand
APIs produced via synthetic routes and those serving innovative (rather than generic) medications hold major market share, driven by the need for complex, differentiated offerings
Commercial supply dominates workflow
A significant portion of CDMO revenue comes from commercial manufacturing, underlining the importance of end-to-end capabilities-from development to large-scale production
Asia-Pacific delivers fastest growth; North America leads in value
North America continues to account for a large portion of market share due to established biopharma industries and regulatory infrastructure. Meanwhile, Asia-Pacific-led by India and China-is expanding rapidly, driven by cost effectiveness and expanding capacity.
These trends illustrate the Active Pharmaceutical Ingredients CDMO Market Growth, particularly where advanced therapeutic areas and global outsourcing intersect.
Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/active-pharmaceutical-ingredients-cdmo-market?utm_source=openpr
Market Segmentation of the Active Pharmaceutical Ingredients CDMO Market
Here is the Active Pharmaceutical Ingredients CDMO Market Segmentation, as defined in the Mordor Intelligence report
By Molecule Size
Small Molecule
Large / Biologic Molecule
By Synthesis Type
Synthetic Chemical
Biological (Fermentation / Cell Culture)
By API Complexity
Standard Potency APIs
Highly-Potent APIs (HPAPIs)
By Service Type
Process R&D & Route Scouting
cGMP Scale-Up & Commercial Manufacturing
Integrated End-to-End Services
By Therapeutic Area
Oncology
Cardiovascular & Metabolic
Anti-Infectives
Central Nervous System
Respiratory
Gastrointestinal & Hepatology
Dermatology & Aesthetics
Immunology & Rare Diseases
By Customer Type
Big Pharma companies
Mid-Size Pharma
Small Biotech
Others
By Phase
Pre-clinical
Phase I
Phase II
Phase III
Commercial
By Geography
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
This segmentation highlights the comprehensive scope of the Active Pharmaceutical Ingredients CDMO Industry, spanning diverse product types, therapeutic fields, and global regions.
Explore Our Full Library of Healthcare Industry Research Reports
https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=openpr
Key Players in the Active Pharmaceutical Ingredients CDMO Industry
Leading companies in the Active Pharmaceutical Ingredients CDMO Market Share include:
Catalent, Inc.
Cambrex Corporation
Lonza Group
Recipharm AB
Astorg (Corden Pharma)
These firms are recognized for offering wide-ranging capabilities-from early-stage API development to full-scale commercial production. They form the backbone of the global Active Pharmaceutical Ingredients CDMO Industry, delivering specialist services to pharmaceutical clients worldwide.
To know more about the major players in the market, visit: https://www.mordorintelligence.com/industry-reports/active-pharmaceutical-ingredients-cdmo-market/companies?utm_source=openpr
Conclusion
The market demand is driven by oncology pipelines, synthetic and innovative drugs, and commercial-scale supply needs. Asia-Pacific is expanding rapidly, while North America retains its leading position in market value.
A diverse array of CDMOs-from global players to regional specialists-is meeting the industry's rising need for integrated services. As pharmaceutical development continues to move toward complex molecules and biologics, the Active Pharmaceutical Ingredients CDMO Market Growth appears set to continue.
For complete Active Pharmaceutical Ingredients CDMO Market Analysis, visit the Mordor Intelligence page: https://www.mordorintelligence.com/industry-reports/active-pharmaceutical-ingredients-cdmo-market?utm_source=openpr
Industry Related Reports
Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market: The Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Report is Segmented by Service Type (API Manufacturing, and More), Molecule Type (Small Molecule, and More), Dosage Form (Solid Oral, Sterile Injectables, and More), Therapeutic Area (Oncology, Metabolic and Endocrine, and More), and Geography.
Get More Insights: https://www.mordorintelligence.com/industry-reports/pharmaceutical-contract-development-and-manufacturing-organization-cdmo-market?utm_source=openpr
China Active Pharmaceutical Ingredients (API) Market: The Chinese Active Pharmaceutical Ingredients (API) Market Report is Segmented by Business Mode (Captive API and Merchant API), Synthesis Type (Synthetic and Biotech), Drug Type (Generic and Branded), and Application (Cardiology, Oncology, Pulmonology, Neurology, Orthopedic, Ophthalmology, and Other Applications).
Get More Insights: https://www.mordorintelligence.com/industry-reports/china-active-pharmaceutical-ingredients-market?utm_source=openpr
Veterinary Active Pharmaceutical Ingredients (API) Market: The report covers Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market and it is Segmented by Product (Antiparasitic, Anti-infectives, Vaccines, NSAIDs, and Others), Synthesis Type (Chemical Based API, Biological API, and Highly potent API (HPAPI)), Service Type (In House, and Contract Outsourcing) and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America).
Get More Insights: https://www.mordorintelligence.com/industry-reports/veterinary-active-pharmaceutical-ingredients-manufacturing-market?utm_source=openpr
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Active Pharmaceutical Ingredients CDMO Market to Reach USD 193.8 Billion by 2030 with Strong Growth in Oncology, Asia-Pacific Expansion here
News-ID: 4165659 • Views: …
More Releases from Mordor Intelligence
Saudi Arabia Real Estate Market Size to Reach USD 109.63 Billion by 2030, Driven …
Mordor Intelligence has published a new report on the "Saudi Arabia Real Estate Market" offering a comprehensive analysis of trends, growth drivers, and future projections
Introduction: Rising Prospects in the Saudi Arabia Real Estate Market
The Saudi Arabia Real Estate Market is estimated at USD 74.99 billion in 2025 and is expected to reach USD 109.63 billion by 2030, growing at a CAGR of 7.89% during the forecast period (2025-2030).…
Non Woven Fabric Market Size to Reach USD 81.96 Billion and CAGR 6.11% by 2030 D …
Non Woven Fabric Market Introduction:
According to the Non‐Woven Fabric Market report by Mordor Intelligence, the market is forecast to grow steadily, reaching USD 81.96 billion by 2030, up from USD 57.21 billion in 2024, with a compound annual growth rate (CAGR) of 6.11% during the period from 2025 to 2030.
This steady rise in demand is being led by increased use of non-woven fabrics in healthcare-think surgical gowns, face masks, drapes,…
Hydrochloric Acid Market Size expected to rise Reach 9.51 Million Tons by 2030 o …
Hydrochloric Acid Market is projected to grow significantly, rising from approximately 7.29 million tons in 2025 to 9.51 million tons by 2030, at a steady compound annual growth rate (CAGR) of 5.46%. This substantial increase reflects the essential role hydrochloric acid plays across diverse industrial processes, including steel pickling, water treatment, and chemical manufacturing.
As global industries continue to expand and enforce stricter environmental regulations, hydrochloric acid remains a key…
Veterinary Vaccines Market Size to Reach USD 15.51 Billion by 2030; Driven by In …
Mordor Intelligence has published a new report on the "Veterinary Vaccines Market" offering a comprehensive analysis of trends, growth drivers, and future projection
The Veterinary Vaccines Market Size is expected to increase from USD 10.21 billion in 2025 to USD 15.51 billion by 2030, registering a steady CAGR of 8.72% over this period. Growth is supported by the rising number of pet adoptions, increasing incidences of zoonotic and livestock diseases,…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
